SCHEMBL9868264

SCHEMBL9868264

COC(=O)/C(C#N)=N/Nc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 15/20 0.58
NPSR1 Q6W5P4 3/20 0.58
KDM4E B2RXH2 2/20 0.58
GAA P10253 2/20 0.58
SMN1; SMN2 Q16637 7/20 0.54
HTT P42858 6/20 0.54
LMNA P02545 5/20 0.54
NPC1 O15118 4/20 0.54
RAB9A P51151 4/20 0.54
ALOX12 P18054 4/20 0.54
NPY1R P25929 1/20 0.54
NPY2R P49146 1/20 0.54
MEN1 O00255 7/20 0.50
KMT2A Q03164 7/20 0.50
ALDH1A1 P00352 5/20 0.48
MAPK1 P28482 3/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9868268 1.00 MAPT (0.58) MAPTNPSR1KDM4EGAASMN1; SMN2
SCHEMBL9868178 0.83 MAPT (0.65) MAPTNPSR1KDM4EGAASMN1; SMN2
SCHEMBL9868180 0.83 MAPT (0.65) MAPTNPSR1KDM4EGAASMN1; SMN2
SCHEMBL9868710 0.83 MAPT (0.67) MAPTNPSR1GAASMN1; SMN2HTT
SCHEMBL9868712 0.83 MAPT (0.67) MAPTNPSR1GAASMN1; SMN2HTT
SCHEMBL24706356 0.81 MAPT (0.49) MAPTNPSR1KDM4EGAASMN1; SMN2
SCHEMBL22130084 0.81 MAPT (0.49) MAPTNPSR1KDM4EGAASMN1; SMN2
SCHEMBL922712 0.79 MAPT (0.81) MAPTNPSR1KDM4EGAASMN1; SMN2
SCHEMBL922713 0.79 MAPT (0.81) MAPTNPSR1KDM4EGAASMN1; SMN2
SCHEMBL24599839 0.78 MAPT (0.56) MAPTNPSR1KDM4EGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0412211-A1 Cancer therapy system THERAPEUTICAL SYSTEMS CORPORATION (US) 1991-02-13 EP claimed
US-4935450-A Cancer therapy system for effecting oncolysis of malignant neoplasms THERAPEUTICAL SYSTEMS CORPORATION (US) 1990-06-19 US claimed